Proteomic analysis of beryllium-induced genotoxicity in an Escherichia coli mutant model system

Proteomics

Volumn 6, Issue 5, 2006, Pages 1663-1675

  Taylor McCabe, Kirsten J ^a   Wang, Zaolin ^a   Sauer, Nancy N ^a   Marrone, Babetta L ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Beryllium; Comutagenesis; E. coli; Mutagenesis

Indexed keywords

BERYLLIUM SULFATE; METHYLNITRONITROSOGUANIDINE; MUTAGENIC AGENT;

ANALYTIC METHOD; ARTICLE; ATOMIC BOMB; BERYLLIOSIS; CONTROLLED STUDY; DUST; ESCHERICHIA COLI; FUME; GENOTOXICITY; INHALATION; LUNG CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELTING POINT; MODEL; MUTAGENICITY; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

BERYLLIUM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ESCHERICHIA COLI;

EID: 33645053764     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200500190     Document Type: Article

References (34)

1. Newman, L. S., Maier, L. A., Nemery, B., Interstitial Lung Disease, BC Decker Inc., London 1998, pp. 367-392.
2. Beryllium and Beryllium Compounds, Tenth Report on Carcinogens, U.S. Department of Health and Human Services, Washington, D.C. 2003.
3. Sanderson, W. T., Ward, E. M., Steenland, K., Petersen, M. R., Am. J. Ind. Med. 2001, 39, 133-144.
4. IARC (International Agency for Research on Cancer), IARC Monogr Eval Carcinog Risk Chem Hum. 1993, 58, 1-145.
5. Bianchi, V., Celotti, L., Lanfranchi, G., Majone, F., Marin, G. et al., Mutat. Res. 1983, 117, 279-300.
6. Marzin, D. R., Phi, H. V., Mutat. Res. 1985, 155, 49-51.
7. Roy, N. K., Rossman, T. G., Mutat. Res. 1992, 298, 97-103.
8. Hartwig, A., Beyersmann, D., Biol. Trace Elem. Res. 1989, 21, 359-365.
9. Gordon, T., Bowser, D., Mutat. Res. 2003, 535, 99-105.
10. Ashby, J., Ishidate, Jr., M., Stoner, G. D., Morgan, M. A., Mutat. Res. 1990, 240, 217-225.
11. Kuroda, K., Endo, G., Okamoto, A., Yoo, Y. S., Horiguchi, S., Mutat. Res. 1991, 264, 163-170.
12. Simmon, V. F., J. Natl. Cancer Inst. 1979, 62, 893-899.
13. Rossman, T. G., Molina, M., Environ. Mutagen 1986, 8, 263-271.
14. Tso, W. W., Fung, W. P., Toxicol. Lett. 1981, 8, 195-200.
15. Zakour, R. A., Glickman, B. W., Mutat. Res. 1984, 726, 9-18.
16. Leonard, A., Lauwerys, R., Mutat. Res. 1987, 186, 35-42.
17. Miyaki, M., Akamatsu, N., Ono, T., Koyama, H., Mutat. Res. 1979, 68, 259-263.
18. Rabilloud, T., Method Mol. Biol. 1999, 772, 297-305.
19. Janerom, D. R., Hreniuk, D., Sharif, H. M., Am. J. Physiol. 1994, 226, C179-C188.
20. Xu, Z. X., Fox, L., Melethil, S., Winberg, L., Badr, M., J. Pharm. Exp. Ther. 1990, 254, 301-305.
21. Liliom, K., Wagner, G., Pacz, A, Casante, M., Kovacs, J., Ovadi, J., Eur. J. Biochem. 2000, 267, 4731-4739.
22. Lewis, C. P. L., Demedts, M., Nemery, B., Am. J. Resp. Mol. Biol. 1991, 5, 163-169.
23. Keizer, T., Sauer, N. N., McCleskey, T. M., J. Am. Chem. Soc. 2004, 126, 9484-9485.
24. Bae, W., Chen, X., Mol. Cell Proteom. 2004, 3, 596-607.
25. Haley, P. J., Finch, G. L., Hoover, M. D., Cuddihy, R. G., Fund. Appl. Toxicol. 1990, 15, 767-778.
26. Lindenschmidt, R. C., Sendelbach, L. E., Witschi, H. P., Price, D. J., Fleming, J., Joshi, J. G., Toxicol. Appl. Pharm. 1986, 82, 344-350.
27. Soliman, K. F., Brain Res. 2004, 1104, 29-44.
28. Schenk, G., Duggleby, R. G., Nixon, P. F., Int. J. Biochem Cell Biol. 1998, 30, 1297-1318.
29. Cooper, S. J., Leonard, G. A., McSweeney, S. M. et al., Structure 1996, 4, 1303-1315.
30. Encyclopedia of Molecular Medicine, 5 Volumes, John Wiley & Sons, Inc., New York, 2001.
31. Jia, J., Huang, W. et al., Structure 1996, 4, 715-724.
32. Scott, B. L., Wang, Z., Marrone, B. L., Sauer, N. N., J. Inorg. Biochem. 2003, 94, 5-13.
33. Sirover, M. A., Loeb, L., Science 1976, 194, 1434-1436.
34. Togna, G., Togna, A. R., Russo, P., Caprino, L., Toxicol. Appl. Pharm. 1997, 144, 262-267.